Crescita Therapeutics (TSX:CTX) Total Assets : C$24.07 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Crescita Therapeutics Total Assets?

Crescita Therapeutics's Total Assets for the quarter that ended in Mar. 2024 was C$24.07 Mil.

During the past 12 months, Crescita Therapeutics's average Total Assets Growth Rate was -17.20% per year. During the past 3 years, the average Total Assets Growth Rate was 6.60% per year. During the past 5 years, the average Total Assets Growth Rate was -1.00% per year.

During the past 10 years, Crescita Therapeutics's highest 3-Year average Total Assets Growth Rate was 199.00%. The lowest was -7.10%. And the median was 4.80%.

Total Assets is connected with ROA %. Crescita Therapeutics's annualized ROA % for the quarter that ended in Mar. 2024 was -10.29%. Total Assets is also linked to Revenue through Asset Turnover. Crescita Therapeutics's Asset Turnover for the quarter that ended in Mar. 2024 was 0.21.

Crescita Therapeutics Total Assets Historical Data

The historical data trend for Crescita Therapeutics's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Crescita Therapeutics Total Assets Chart

Crescita Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

26.84

26.83

28.92

28.48

24.60

Crescita Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Assets	Get a 7-Day Free Trial															27.84	26.53	25.37	24.60	24.07

Crescita Therapeutics Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Crescita Therapeutics's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	18.822	+	5.776
	=	24.60

Crescita Therapeutics's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2024 )	+	Total Liabilities (Q: Mar. 2024 )
	=	18.144	+	5.925
	=	24.07

Crescita Therapeutics (TSX:CTX) Total Assets Explanation

Total Assets is connected with ROA %.

Crescita Therapeutics's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %	=	Net Income (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	-2.504	/	( (24.598	+	24.069)	/ 2 )
	=	-2.504	/	24.3335
	=	-10.29 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Crescita Therapeutics's Asset Turnover for the quarter that ended in Mar. 2024 is

	Asset Turnover
=	Revenue (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
=	4.996	/	( (24.598	+	24.069)	/ 2 )
=	4.996	/	24.3335
=	0.21

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Crescita Therapeutics Total Assets Related Terms

Thank you for viewing the detailed overview of Crescita Therapeutics's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Crescita Therapeutics (TSX:CTX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Crescita Therapeutics Inc (TSX:CTX) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

CRRTF:USA

Address

2805, Place Louis-R-Renaud, Laval, QC, CAN, H7V 0A3

Website

https://www.crescitatherapeutics.com

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The company has three reportable segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The firm generates its revenue in the form of product sales and out-licensing revenue.

Executives

Knight Therapeutics Inc.

10% Security Holder

Crescita Therapeutics (TSX:CTX) Headlines

No Headlines